V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results

BACKGROUND: Long acting bronchodilators are the standard of care in the management of chronic obstructive pulmonary disease (COPD). The aim of this study was to investigate the efficacy and safety of V0162, a novel anticholinergic agent with bronchodilator properties, in preclinical models and in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Devillier, Philippe, Garrigue, Eric, D’Auzers, Guillaume, Monjotin, Nicolas, Similowski, Thomas, Clerc, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462001/
https://www.ncbi.nlm.nih.gov/pubmed/26050967
http://dx.doi.org/10.1186/s12931-015-0227-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462001/
https://www.ncbi.nlm.nih.gov/pubmed/26050967
http://dx.doi.org/10.1186/s12931-015-0227-1

Ejemplares similares